Literature DB >> 11997083

Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the cytosolic gp91phox C-terminal tail.

Marie José Stasia1, Bernard Lardy, Andres Maturana, Pascale Rousseau, Cécile Martel, Pierre Bordigoni, Nicolas Demaurex, Françoise Morel.   

Abstract

We report here two atypical cases of X-linked CGD patients (first cousins) in which cytochrome b(558) is present at a normal level but is not functional (X91+). The mutations were localized by single-strand conformational polymorphism of reverse transcriptase-polymerase chain reaction amplified fragments and then identified by sequence analysis. They consisted in two base substitutions (C919 to A and C923 to G), changing His303 to Asn and Pro304 to Arg in the cytosolic gp91phox C-terminal tail. Mismatched polymerase chain reaction and genomic DNA sequencing showed that mothers had both wild-type and mutated alleles, confirming that this case was transmitted in an X-linked fashion. A normal amount of FAD was found in neutrophil membranes, both in the X91+ patients and their parents. Epstein-Barr virus-transformed B lymphocytes from the X91+ patients acidified normally upon stimulation with arachidonic acid, indicating that the mutated gp91phox still functioned as a proton channel. A cell-free translocation assay demonstrated that the association of the cytosolic factors p47phox and p67phox with the membrane fraction was strongly disrupted. We concluded that residues 303 and 304 are crucial for the stable assembly of the NADPH oxidase complex and for electron transfer, but not for its proton channel activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997083     DOI: 10.1016/s0925-4439(01)00110-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Assembly of the phagocyte NADPH oxidase.

Authors:  William M Nauseef
Journal:  Histochem Cell Biol       Date:  2004-08-04       Impact factor: 4.304

Review 2.  Hematologically important mutations: X-linked chronic granulomatous disease (third update).

Authors:  Dirk Roos; Douglas B Kuhns; Anne Maddalena; Joachim Roesler; Juan Alvaro Lopez; Tadashi Ariga; Tadej Avcin; Martin de Boer; Jacinta Bustamante; Antonio Condino-Neto; Gigliola Di Matteo; Jianxin He; Harry R Hill; Steven M Holland; Caroline Kannengiesser; M Yavuz Köker; Irina Kondratenko; Karin van Leeuwen; Harry L Malech; László Marodi; Hiroyuki Nunoi; Marie-José Stasia; Anna Maria Ventura; Carl T Witwer; Baruch Wolach; John I Gallin
Journal:  Blood Cells Mol Dis       Date:  2010-08-21       Impact factor: 3.039

3.  Role of putative second transmembrane region of Nox2 protein in the structural stability and electron transfer of the phagocytic NADPH oxidase.

Authors:  Antoine Picciocchi; Franck Debeurme; Sylvain Beaumel; Marie-Claire Dagher; Didier Grunwald; Algirdas J Jesaitis; Marie-José Stasia
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

4.  Down-regulation of NOX2 activity in phagocytes mediated by ATM-kinase dependent phosphorylation.

Authors:  Sylvain Beaumel; Antoine Picciocchi; Franck Debeurme; Corinne Vivès; Anne-Marie Hesse; Myriam Ferro; Didier Grunwald; Heather Stieglitz; Pahk Thepchatri; Susan M E Smith; Franck Fieschi; Marie José Stasia
Journal:  Free Radic Biol Med       Date:  2017-09-13       Impact factor: 7.376

5.  Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.

Authors:  Baruch Wolach; Arnon Broides; Tal Zeeli; Ronit Gavrieli; Martin de Boer; Karin van Leeuwen; Jacov Levy; Dirk Roos
Journal:  J Clin Immunol       Date:  2011-05-21       Impact factor: 8.317

6.  Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.

Authors:  Marie José Stasia; Pierre Bordigoni; Daniel Floret; Jean Paul Brion; Cécile Bost-Bru; Gérard Michel; Pierre Gatel; Denis Durant-Vital; Marie Antoinette Voelckel; Xing Jun Li; Michèle Guillot; Elisabeth Maquet; Cécile Martel; Françoise Morel
Journal:  Hum Genet       Date:  2004-11-06       Impact factor: 4.132

7.  Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.

Authors:  Clara Bionda; Xing Jun Li; Robin van Bruggen; Michel Eppink; Dirk Roos; Françoise Morel; Marie-José Stasia
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

8.  First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.

Authors:  Faris G Bakri; Cécile Martel; Najwa Khuri-Bulos; Azmi Mahafzah; Mohammad S El-Khateeb; Adel M Al-Wahadneh; Wail A Hayajneh; Hanan A Hamamy; Elisabeth Maquet; Michelle Molin; Marie José Stasia
Journal:  J Clin Immunol       Date:  2008-09-05       Impact factor: 8.317

9.  Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.

Authors:  Cécile Martel; Michelle Mollin; Sylvain Beaumel; Jean Paul Brion; Charles Coutton; Véronique Satre; Gaëlle Vieville; Mary Callanan; Christine Lefebvre; Alexandra Salmon; Anne Pagnier; Dominique Plantaz; Cécile Bost-Bru; Laurence Eitenschenck; Isabelle Durieu; Daniel Floret; Claire Galambrun; Hervé Chambost; Gérard Michel; Jean-Louis Stephan; Olivier Hermine; Stéphane Blanche; Nathalie Blot; Hervé Rubié; Guillaume Pouessel; Stephanie Drillon-Haus; Bernard Conrad; Klara M Posfay-Barbe; Zuzana Havlicekova; Tamara Voskresenky-Baricic; Kelecic Jadranka; Maria Cristina Arriazu; Luis Alberto Garcia; Lamia Sfaihi; Lamia Sfaihi Ben Mansour; Pierre Bordigoni; Marie José Stasia
Journal:  J Clin Immunol       Date:  2012-05-05       Impact factor: 8.317

Review 10.  Activation and assembly of the NADPH oxidase: a structural perspective.

Authors:  Yvonne Groemping; Katrin Rittinger
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.